MapLight Therapeutics MPLT
NASDAQ MPLT
$7.44 +0.16 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2026)

Updated

MapLight Therapeutics' Non-Current Assets was $49.56 million in Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at MapLight Therapeutics came in at $154.84 million, up 593.9% from FY2024.

  • In earlier years, Non-Current Assets was $22.31 million in FY2024.
  • Quarterly Non-Current Assets has moved between $11.92 million (Q3 2025) and $154.84 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 141.07 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 110.20 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 87.87 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 34.86 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 159.99 Bn
10 MapLight Therapeutics 340.28 Mn 340.28 Mn - 49.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.56 Mn
Dec 31, 2025 154.84 Mn
Sep 30, 2025 11.92 Mn
Dec 31, 2024 22.31 Mn
API Access

MapLight Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=MPLT&period=max&api_key=YOUR_API_KEY